Dopamine infusion: a possible cause of undiagnosed congenital hypothyroidism in preterm infants

Pediatr Crit Care Med. 2006 May;7(3):249-51. doi: 10.1097/01.PCC.0000216680.22950.D9.

Abstract

Objective: To describe the possibility that dopamine infusion can prevent early diagnosis of congenital hypothyroidism.

Design: Case report.

Setting: Medical neonatal intensive care unit of a tertiary academic medical center.

Patients: We report four preterm newborns affected by transient primary congenital hypothyroidism who showed low serum thyroxine and normal thyroid-stimulating hormone concentrations on primary screening performed during treatment with dopamine.

Interventions: Thyroid reevaluation screening after dopamine discontinuation.

Measurements and main results: Thyroid reevaluation showed elevated thyroid-stimulating hormone levels.

Conclusion: We emphasize that dopamine capacity to suppress thyroid-stimulating hormone could prevent early diagnosis of congenital hypothyroidism. We suggest all newborns to be tested simultaneously for thyroid-stimulating hormone and thyroxine values at primary screening. A reevaluation of thyroid hormones after dopamine discontinuation is advisable in patients treated with dopamine.

Publication types

  • Case Reports

MeSH terms

  • Congenital Hypothyroidism / chemically induced*
  • Dopamine / administration & dosage
  • Dopamine / adverse effects*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infusions, Intravenous
  • Male
  • Neonatal Screening
  • Thyrotropin / drug effects

Substances

  • Thyrotropin
  • Dopamine